Pulmatrix Ebit vs Operating Income Analysis

PULM Stock

USD 6.50 0.21 3.13%

Pulmatrix financial indicator trend analysis is much more than just breaking down Pulmatrix prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pulmatrix is a good investment. Please check the relationship between Pulmatrix Ebit and its Operating Income accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pulmatrix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

To learn how to invest in Pulmatrix Stock, please use our How to Invest in Pulmatrix guide.

Ebit vs Operating Income

Ebit vs Operating Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pulmatrix Ebit account and Operating Income. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Pulmatrix's Ebit and Operating Income is 0.92. Overlapping area represents the amount of variation of Ebit that can explain the historical movement of Operating Income in the same time period over historical financial statements of Pulmatrix, assuming nothing else is changed. The correlation between historical values of Pulmatrix's Ebit and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebit of Pulmatrix are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Ebit i.e., Pulmatrix's Ebit and Operating Income go up and down completely randomly.

Correlation Coefficient

0.92

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Ebit

Operating Income

Operating Income is the amount of profit realized from Pulmatrix operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Pulmatrix is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Most indicators from Pulmatrix's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pulmatrix current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pulmatrix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

To learn how to invest in Pulmatrix Stock, please use our How to Invest in Pulmatrix guide.As of the 29th of April 2025, Enterprise Value is likely to grow to about 16.8 M, while Selling General Administrative is likely to drop about 6.7 M.

Pulmatrix fundamental ratios Correlations

	Other Current Liab	Total Stockholder Equity	Retained Earnings	Accounts Payable	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Assets	Short Long Term Debt Total	Total Current Liabilities	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Non Current Liabilities Total	Inventory	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock
Other Current Liab		0.0	-0.35	0.26	0.18	0.22	0.38	0.1	-0.52	0.21	0.12	0.5	-0.34	-0.02	0.25	0.04	-0.02	0.1	0.1	-0.26	0.07	0.24	0.1	0.0	-0.52	0.24
Total Stockholder Equity	0.0		-0.46	0.51	0.35	0.74	0.58	0.93	-0.43	0.25	0.26	0.39	-0.82	0.91	0.36	0.63	0.91	0.01	-0.15	0.58	0.13	0.48	0.21	0.88	-0.39	0.45
Retained Earnings	-0.35	-0.46		-0.8	-0.81	-0.7	-0.97	-0.55	0.86	-0.42	-0.41	-0.88	0.74	-0.49	-0.25	-0.4	-0.49	-0.2	0.03	-0.13	0.06	-0.51	-0.37	-0.51	0.9	-0.93
Accounts Payable	0.26	0.51	-0.8		0.62	0.63	0.82	0.59	-0.68	0.25	0.71	0.7	-0.58	0.4	0.57	0.58	0.4	0.08	-0.01	0.44	-0.07	0.53	0.69	0.41	-0.76	0.68
Common Stock Shares Outstanding	0.18	0.35	-0.81	0.62		0.49	0.73	0.34	-0.45	0.02	0.45	0.49	-0.55	0.46	-0.17	0.44	0.46	0.02	-0.53	0.09	-0.44	0.2	0.44	0.45	-0.54	0.91
Other Current Assets	0.22	0.74	-0.7	0.63	0.49		0.75	0.84	-0.71	0.56	0.34	0.74	-0.75	0.69	0.5	0.43	0.69	0.32	0.02	0.44	0.05	0.73	0.3	0.72	-0.71	0.6
Other Stockholder Equity	0.38	0.58	-0.97	0.82	0.73	0.75		0.67	-0.87	0.48	0.45	0.88	-0.81	0.58	0.34	0.48	0.58	0.22	0.02	0.23	0.04	0.6	0.4	0.6	-0.89	0.87
Total Assets	0.1	0.93	-0.55	0.59	0.34	0.84	0.67		-0.57	0.56	0.39	0.57	-0.85	0.91	0.45	0.65	0.91	0.31	0.0	0.69	0.27	0.77	0.33	0.92	-0.52	0.47
Short Long Term Debt Total	-0.52	-0.43	0.86	-0.68	-0.45	-0.71	-0.87	-0.57		-0.58	-0.23	-0.98	0.65	-0.38	-0.5	-0.24	-0.38	-0.28	-0.3	0.01	-0.25	-0.61	-0.18	-0.42	0.98	-0.67
Total Current Liabilities	0.21	0.25	-0.42	0.25	0.02	0.56	0.48	0.56	-0.58		0.15	0.65	-0.52	0.42	0.26	0.12	0.42	0.85	0.51	0.37	0.6	0.89	0.09	0.51	-0.49	0.22
Property Plant And Equipment Net	0.12	0.26	-0.41	0.71	0.45	0.34	0.45	0.39	-0.23	0.15		0.28	-0.25	0.28	0.34	0.8	0.28	0.08	-0.2	0.57	-0.23	0.48	0.99	0.28	-0.31	0.38
Current Deferred Revenue	0.5	0.39	-0.88	0.7	0.49	0.74	0.88	0.57	-0.98	0.65	0.28		-0.65	0.37	0.49	0.24	0.37	0.39	0.29	0.06	0.19	0.69	0.24	0.42	-0.98	0.69
Net Debt	-0.34	-0.82	0.74	-0.58	-0.55	-0.75	-0.81	-0.85	0.65	-0.52	-0.25	-0.65		-0.86	-0.2	-0.5	-0.86	-0.27	0.05	-0.45	-0.21	-0.62	-0.18	-0.86	0.61	-0.71
Cash	-0.02	0.91	-0.49	0.4	0.46	0.69	0.58	0.91	-0.38	0.42	0.28	0.37	-0.86		0.05	0.63	1.0	0.23	-0.27	0.61	0.21	0.59	0.21	0.99	-0.31	0.53
Non Current Assets Total	0.25	0.36	-0.25	0.57	-0.17	0.5	0.34	0.45	-0.5	0.26	0.34	0.49	-0.2	0.05		0.24	0.05	0.02	0.47	0.34	0.12	0.45	0.33	0.06	-0.53	-0.01
Non Currrent Assets Other	0.04	0.63	-0.4	0.58	0.44	0.43	0.48	0.65	-0.24	0.12	0.8	0.24	-0.5	0.63	0.24		0.63	0.01	-0.24	0.6	-0.19	0.44	0.79	0.62	-0.26	0.39
Cash And Short Term Investments	-0.02	0.91	-0.49	0.4	0.46	0.69	0.58	0.91	-0.38	0.42	0.28	0.37	-0.86	1.0	0.05	0.63		0.23	-0.27	0.61	0.21	0.59	0.21	0.99	-0.31	0.53
Net Receivables	0.1	0.01	-0.2	0.08	0.02	0.32	0.22	0.31	-0.28	0.85	0.08	0.39	-0.27	0.23	0.02	0.01	0.23		0.43	0.33	0.4	0.73	0.08	0.34	-0.22	0.03
Common Stock Total Equity	0.1	-0.15	0.03	-0.01	-0.53	0.02	0.02	0.0	-0.3	0.51	-0.2	0.29	0.05	-0.27	0.47	-0.24	-0.27	0.43		-0.06	0.48	0.27	-0.18	-0.21	-0.23	-0.31
Non Current Liabilities Total	-0.26	0.58	-0.13	0.44	0.09	0.44	0.23	0.69	0.01	0.37	0.57	0.06	-0.45	0.61	0.34	0.6	0.61	0.33	-0.06		0.13	0.63	0.54	0.62	0.0	0.09
Inventory	0.07	0.13	0.06	-0.07	-0.44	0.05	0.04	0.27	-0.25	0.6	-0.23	0.19	-0.21	0.21	0.12	-0.19	0.21	0.4	0.48	0.13		0.43	-0.32	0.25	-0.08	-0.18
Total Liab	0.24	0.48	-0.51	0.53	0.2	0.73	0.6	0.77	-0.61	0.89	0.48	0.69	-0.62	0.59	0.45	0.44	0.59	0.73	0.27	0.63	0.43		0.42	0.66	-0.57	0.33
Property Plant And Equipment Gross	0.1	0.21	-0.37	0.69	0.44	0.3	0.4	0.33	-0.18	0.09	0.99	0.24	-0.18	0.21	0.33	0.79	0.21	0.08	-0.18	0.54	-0.32	0.42		0.22	-0.27	0.32
Total Current Assets	0.0	0.88	-0.51	0.41	0.45	0.72	0.6	0.92	-0.42	0.51	0.28	0.42	-0.86	0.99	0.06	0.62	0.99	0.34	-0.21	0.62	0.25	0.66	0.22		-0.35	0.53
Short Term Debt	-0.52	-0.39	0.9	-0.76	-0.54	-0.71	-0.89	-0.52	0.98	-0.49	-0.31	-0.98	0.61	-0.31	-0.53	-0.26	-0.31	-0.22	-0.23	0.0	-0.08	-0.57	-0.27	-0.35		-0.72
Common Stock	0.24	0.45	-0.93	0.68	0.91	0.6	0.87	0.47	-0.67	0.22	0.38	0.69	-0.71	0.53	-0.01	0.39	0.53	0.03	-0.31	0.09	-0.18	0.33	0.32	0.53	-0.72

Click cells to compare fundamentals

Pulmatrix Account Relationship Matchups

Pulmatrix fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Other Current Liab	1.8M	893K	(198K)	781K	120K	126K
Total Stockholder Equity	23.1M	47.4M	31.1M	18.0M	8.9M	8.5M
Retained Earnings	(234.5M)	(254.6M)	(273.5M)	(287.6M)	(297.2M)	(282.3M)
Accounts Payable	851K	839K	1.2M	1.9M	809K	847.6K
Common Stock Shares Outstanding	1.4M	2.7M	3.4M	3.7M	3.7M	3.8M
Other Current Assets	723K	871K	1.1M	742K	399K	544.3K
Other Stockholder Equity	257.6M	301.0M	304.6M	305.6M	306.1M	188.0M
Total Assets	38.2M	58.8M	41.0M	34.0M	9.9M	9.4M
Short Long Term Debt Total	1.7M	2.3M	857K	8.8M	7.9M	7.8M
Total Current Liabilities	8.3M	4.4M	5.0M	3.9M	929K	882.6K
Property Plant And Equipment Net	900K	1.9M	2.4M	945K	11.5M	0.0
Current Deferred Revenue	4.2M	939K	1.3M	618K	710.7K	746.2K
Net Debt	(29.9M)	(51.6M)	(34.8M)	(10.4M)	(9.5M)	(10.0M)
Cash	31.7M	53.8M	35.6M	19.2M	9.5M	9.0M
Non Current Assets Total	5.6M	4.0M	2.8M	13.1M	23K	21.9K
Cash And Short Term Investments	31.7M	53.8M	35.6M	19.2M	9.5M	9.0M
Net Receivables	0.0	7.2M	84K	67K	1.3M	928K
Liabilities And Stockholders Equity	38.2M	58.8M	41.0M	34.0M	9.9M	9.4M
Non Current Liabilities Total	6.8M	6.9M	4.8M	12.1M	67K	63.7K
Total Liab	15.0M	11.4M	9.8M	16.0M	996K	946.2K
Property Plant And Equipment Gross	900K	361.0	2.4M	945K	13.2M	0.0
Total Current Assets	32.5M	54.8M	38.1M	20.8M	9.9M	9.4M
Short Term Debt	2.3M	2.9M	1.7M	429K	386.1K	366.8K
Net Tangible Assets	7.4M	19.6M	46.4M	31.1M	35.8M	37.6M
Other Assets	1.7K	1.6M	1.9M	1.0	1.15	1.09
Property Plant Equipment	270K	1.9M	2.4M	945K	1.1M	991.8K
Net Invested Capital	23.1M	46.4M	31.1M	18.0M	8.9M	8.5M
Net Working Capital	24.3M	50.3M	33.1M	16.9M	9.0M	8.5M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Pulmatrix is a strong investment it is important to analyze Pulmatrix's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pulmatrix's future performance. For an informed investment choice regarding Pulmatrix Stock, refer to the following important reports:

How To Invest In Pulmatrix

Details

Is Pulmatrix Stock a good investment?

Details

What is Pulmatrix's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pulmatrix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

To learn how to invest in Pulmatrix Stock, please use our How to Invest in Pulmatrix guide.

You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmatrix. If investors know Pulmatrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmatrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.62)

Revenue Per Share

2.137

Quarterly Revenue Growth

(1.00)

Return On Assets

(0.20)

Return On Equity

(0.71)

The market value of Pulmatrix is measured differently than its book value, which is the value of Pulmatrix that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmatrix's value that differs from its market value or its book value, called intrinsic value, which is Pulmatrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmatrix's market value can be influenced by many factors that don't directly affect Pulmatrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Pulmatrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmatrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmatrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Pulmatrix Ebit vs Operating Income Analysis

Ebit vs Operating Income

Ebit vs Operating Income Correlation Analysis

Correlation Coefficient

Ebit

Operating Income

Pulmatrix fundamental ratios Correlations

Pulmatrix Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Pulmatrix fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Property Plant And Equipment Gross	+ 0.99	Property Plant And Equipment Net
Total Current Assets	+ 0.99	Cash
Total Current Assets	+ 0.99	Cash And Short Term Investments
Short Term Debt	+ 0.98	Short Long Term Debt Total
Total Assets	+ 0.93	Total Stockholder Equity

Short Term Debt	- 0.98	Current Deferred Revenue
Current Deferred Revenue	- 0.98	Short Long Term Debt Total
Other Stockholder Equity	- 0.97	Retained Earnings
Common Stock	- 0.93	Retained Earnings
Short Term Debt	- 0.89	Other Stockholder Equity
Current Deferred Revenue	- 0.88	Retained Earnings